SynopsisDegarelix (INN) or degarelix acetate (USAN), sold under the brand name Firmagon among others, is a hormonal therapy used in the treatment of prostate cancer. The global Degarelix market was valued at US$ million in 2023 and is anticipated to reach US$ mi.....
SynopsisAn OB/GYN ultrasound probe is a medical device used in obstetrics and gynecology for imaging purposes. It is designed to capture detailed images of the female reproductive system, including the uterus, ovaries, and fetus during pregnancy. The global Obst.....
SynopsisPolio vaccines are vaccines used to prevent poliomyelitis (polio). The global Poliovirus Vaccine market was valued at US$ 709.8 million in 2023 and is anticipated to reach US$ 955.4 million by 2030, witnessing a CAGR of 4.4% during the forecast period 20.....
SynopsisThere are several hemostasis devices that can help cath labs improve efficiency by reducing nursing time in the recovery area, speeding the post-procedural time to patient ambulation and enabling same day percutaneous coronary interventions (PCI). The gl.....
SynopsisTotal Body CT Scanning is a new diagnostic technique that uses computer tomography to help identify potential problems and diseases before symptoms even appear. The global Full Body CT Scanners market was valued at US$ million in 2023 and is anticipated .....
SynopsisThe global Precision Dental Sandblaster market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Precision Dental Sandblaster in various end use industries. T.....
SynopsisCutaneous leishmaniasis is the most common form of leishmaniasis. It is caused by over 15 different species of the protozoan parasite Leishmania, transmitted by infected female sandflies. The global Cutaneous Leishmaniasis Medication market was valued at.....
SynopsisThe global Benign Prostatic Hyperplasia (BPH) Treatment Devices market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on Benign Prostatic Hyp.....
SynopsisEtanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. The global Etanercept market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The.....
SynopsisThe global Lipid Injectable Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Lipid Injectable Drugs is estimated to incr.....
